Four biotech companies announce pricings of IPOs, looking to raise more than $300M
NextCure, Milestone Pharmaceuticals, Cortexyme and Axcella Health all said Wednesday that they would begin trading on the Nasdaq Thursday.
Firm targeting potential bacterial role in Alzheimer’s gets $76 million Series B
Cortexyme has also finished enrolling healthy volunteers in the Phase I study of lead candidate COR388.
presented by
Improving Medical Billing to Cut Payment Bottlenecks
Yusuf Qasim, President of Payments Optimization at Zelis, discussed how the company is transforming healthcare payments from a fragmented, patchwork system into a modern, digital infrastructure.
Breakout Labs backs startups building wearable for the gut, stem cell treatment for bones
A wearable device that could transform how physicians diagnose the underlying causes of GI disorders is one of three innovative early stage life science companies Peter Thiel’s Breakout Labs is backing. The program from the Thiel Foundation provides up to $350,000 for companies to reach certain milestones critical to their development, according to a company […]